论文部分内容阅读
目的探讨新辅助化疗对胃癌术后并发症吻合口瘘发生率的影响。方法对156例进展期胃癌分为对照组与新辅助化疗组后实施手术,新辅助化疗组术前应用FOLFOX6方案化疗,对两组切除术后吻合口瘘发生率进行比较。结果对照组与新辅助化疗组吻合口瘘发生率差异不具有统计学意义。结论新辅助化疗没有增加胃癌切除术后吻合口瘘发生率。
Objective To investigate the effect of neoadjuvant chemotherapy on the incidence of postoperative complications of gastric cancer anastomotic leakage. Methods 156 cases of advanced gastric cancer were divided into control group and neoadjuvant chemotherapy group. The neoadjuvant chemotherapy group was given FOLFOX6 chemotherapy before operation, and the incidence of anastomotic fistula after the resection was compared between the two groups. Results There was no significant difference in the incidence of anastomotic fistula between the control group and the neoadjuvant chemotherapy group. Conclusion Neoadjuvant chemotherapy does not increase the incidence of anastomotic fistula after resection of gastric cancer.